BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 33206639)

  • 1. Antigenicity, stability, and reproducibility of Zika reporter virus particles for long-term applications.
    Whitbeck JC; Thomas A; Kadash-Edmondson K; Grinyo-Escuer A; Stafford LJ; Cheng C; Liao GC; Holtsberg FW; Aman MJ; Simmons G; Davidson E; Doranz BJ
    PLoS Negl Trop Dis; 2020 Nov; 14(11):e0008730. PubMed ID: 33206639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of Virus-Like-Particle Vaccine and Reporter Assay for Zika Virus.
    Garg H; Sedano M; Plata G; Punke EB; Joshi A
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28794019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A high throughput reporter virus particle microneutralization assay for quantitation of Zika virus neutralizing antibodies in multiple species.
    Bohning K; Sonnberg S; Chen HL; Zahralban-Steele M; Powell T; Hather G; Patel HK; Dean HJ
    PLoS One; 2021; 16(4):e0250516. PubMed ID: 33891631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a Novel Reporter Virus Neutralization Test for Serological Diagnosis of Zika and Dengue Virus Infection.
    Shan C; Ortiz DA; Yang Y; Wong SJ; Kramer LD; Shi PY; Loeffelholz MJ; Ren P
    J Clin Microbiol; 2017 Oct; 55(10):3028-3036. PubMed ID: 28768729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroprevalence of Flavivirus Neutralizing Antibodies in Thailand by High-Throughput Neutralization Assay: Endemic Circulation of Zika Virus before 2012.
    Yamanaka A; Matsuda M; Okabayashi T; Pitaksajjakul P; Ramasoota P; Saito K; Fukasawa M; Hanada K; Matsuura T; Muramatsu M; Shioda T; Suzuki R
    mSphere; 2021 Aug; 6(4):e0033921. PubMed ID: 34259560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Plaque Reduction Neutralization Test for the Detection of ZIKV-Specific Antibodies.
    Dimitrova K; Mendoza EJ; Mueller N; Wood H
    Methods Mol Biol; 2020; 2142():59-71. PubMed ID: 32367358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zika virus-like particle vaccine protects AG129 mice and rhesus macaques against Zika virus.
    Vang L; Morello CS; Mendy J; Thompson D; Manayani D; Guenther B; Julander J; Sanford D; Jain A; Patel A; Shabram P; Smith J; Alexander J
    PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009195. PubMed ID: 33711018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single-dose plasmid-launched live-attenuated Zika vaccine induces protective immunity.
    Zou J; Xie X; Luo H; Shan C; Muruato AE; Weaver SC; Wang T; Shi PY
    EBioMedicine; 2018 Oct; 36():92-102. PubMed ID: 30201444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dengue Virus Envelope Dimer Epitope Monoclonal Antibodies Isolated from Dengue Patients Are Protective against Zika Virus.
    Swanstrom JA; Plante JA; Plante KS; Young EF; McGowan E; Gallichotte EN; Widman DG; Heise MT; de Silva AM; Baric RS
    mBio; 2016 Jul; 7(4):. PubMed ID: 27435464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and evaluation of a novel high-throughput image-based fluorescent neutralization test for detection of Zika virus infection.
    Koishi AC; Suzukawa AA; Zanluca C; Camacho DE; Comach G; Duarte Dos Santos CN
    PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006342. PubMed ID: 29543803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incorporation of IgG Depletion in a Neutralization Assay Facilitates Differential Diagnosis of Zika and Dengue in Secondary Flavivirus Infection Cases.
    Calvert AE; Boroughs KL; Laven J; Stovall JL; Luy BE; Kosoy OI; Huang CY
    J Clin Microbiol; 2018 Jun; 56(6):. PubMed ID: 29618505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zika Virus Attenuation by Codon Pair Deoptimization Induces Sterilizing Immunity in Mouse Models.
    Li P; Ke X; Wang T; Tan Z; Luo D; Miao Y; Sun J; Zhang Y; Liu Y; Hu Q; Xu F; Wang H; Zheng Z
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29925661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dengue virus envelope protein domain III-elicited antibodies mediate cross-protection against Zika virus in a mouse model.
    Zhou Y; Chen D; Yang L; Zou W; Duan Z; Zhang Y; Wen J
    Virus Res; 2020 Mar; 278():197882. PubMed ID: 31981774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survey on neutralizing antibodies against Zika virus eighteen months post-outbreak in two southern Thailand communities.
    Densathaporn T; Sangthong R; Sakolnapa M; Surasombatpattana S; Kemapunmanus M; Masrinoul P; Yoksan S; McNeil EB; Chongsuvivatwong V
    BMC Infect Dis; 2020 Dec; 20(1):921. PubMed ID: 33272192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of Zika virus neutralizing antibodies in healthy adults in Vietnam during and after the Zika virus epidemic season: a longitudinal population-based survey.
    Nguyen CT; Moi ML; Le TQM; Nguyen TTT; Vu TBH; Nguyen HT; Pham TTH; Le THT; Nguyen LMH; Phu Ly MH; Ng CFS; Takemura T; Morita K; Hasebe F
    BMC Infect Dis; 2020 May; 20(1):332. PubMed ID: 32393198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism and significance of cell type-dependent neutralization of flaviviruses.
    Mukherjee S; Dowd KA; Manhart CJ; Ledgerwood JE; Durbin AP; Whitehead SS; Pierson TC
    J Virol; 2014 Jul; 88(13):7210-20. PubMed ID: 24741083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a high-throughput colorimetric Zika virus infection assay.
    Müller JA; Harms M; Schubert A; Mayer B; Jansen S; Herbeuval JP; Michel D; Mertens T; Vapalahti O; Schmidt-Chanasit J; Münch J
    Med Microbiol Immunol; 2017 Apr; 206(2):175-185. PubMed ID: 28176006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization of Zika virus envelope protein production for ELISA and correlation of antibody titers with virus neutralization in Mexican patients from an arbovirus endemic region.
    Kim YC; Lopez-Camacho C; Nettleship JE; Rahman N; Hill ML; Silva-Reyes L; Ortiz-Martinez G; Figueroa-Aguilar G; Mar MA; Vivanco-Cid H; Rollier CS; Zitzmann N; Viveros-Sandoval ME; Owens RJ; Reyes-Sandoval A
    Virol J; 2018 Dec; 15(1):193. PubMed ID: 30587198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent Zika and dengue cross-neutralizing antibodies induced by Zika vaccination in a dengue-experienced donor.
    Dussupt V; Sankhala RS; Gromowski GD; Donofrio G; De La Barrera RA; Larocca RA; Zaky W; Mendez-Rivera L; Choe M; Davidson E; McCracken MK; Brien JD; Abbink P; Bai H; Bryan AL; Bias CH; Berry IM; Botero N; Cook T; Doria-Rose NA; Escuer AGI; Frimpong JA; Geretz A; Hernandez M; Hollidge BS; Jian N; Kabra K; Leggat DJ; Liu J; Pinto AK; Rutvisuttinunt W; Setliff I; Tran U; Townsley S; Doranz BJ; Rolland M; McDermott AB; Georgiev IS; Thomas R; Robb ML; Eckels KH; Barranco E; Koren M; Smith DR; Jarman RG; George SL; Stephenson KE; Barouch DH; Modjarrad K; Michael NL; Joyce MG; Krebs SJ
    Nat Med; 2020 Feb; 26(2):228-235. PubMed ID: 32015557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal Analysis of Antibody Cross-neutralization Following Zika Virus and Dengue Virus Infection in Asia and the Americas.
    Montoya M; Collins M; Dejnirattisai W; Katzelnick LC; Puerta-Guardo H; Jadi R; Schildhauer S; Supasa P; Vasanawathana S; Malasit P; Mongkolsapaya J; de Silva AD; Tissera H; Balmaseda A; Screaton G; de Silva AM; Harris E
    J Infect Dis; 2018 Jul; 218(4):536-545. PubMed ID: 29618091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.